Cross-border advisory Checkmate Capital actively facilitates international licensing opportunities across biotech, agtech, waste technology, and energy technology sectors, with recent MOU activity in Asia indicating a readiness to engage cross-border deal flow. Leverage their global reach to identify licensing or strategic partnership opportunities for clients seeking international expansion.

Life sciences focus Recent collaboration with Armstrong Asia and emphasis on cross-border transactions in life sciences and medical technology suggests a strategic niche. Target biotech and medtech firms seeking advisory, transaction support, or licensing deals in Asia-Pacific and North America.

Strategic investment track The firm engages in selective investment activity and has participated in financing rounds such as Precision Livestock Technologies, signaling capability to connect portfolio-style opportunities with capital providers. Use this to position Checkmate as a gateway to strategic investments and co-investment opportunities.

Boutique advisory with broad exposure With a small team yet experience from top-tier financial and legal institutions, Checkmate offers personalized advisory in commercial, transactional, and economic strategy. This can appeal to mid-market clients seeking high-touch services in complex cross-border transactions.

Growing market signals Revenue is in the low-to-mid single-digit millions with a professional network spanning large global banks and firms. This combination indicates potential for expansion services, syndicated deals, and licensing opportunities as clients scale or seek international partnerships.